Sign in
8-K

Current Report

Immunovant, Inc. Filed Acc 0001193125-19-321147

Material agreement · Acquisition or sale completed · Results of operations · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 2.02 Results of operations and financial condition
  • Item 3.02 Unregistered sales of equity securities
  • Item 3.03 Material modification to rights of security holders
  • Item 4.01 Changes in the registrant's certifying accountant
  • Item 5.01 Changes in control of the registrant
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d839382d8k.htm…